Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03023930 · ClinicalTrials.gov registry record · NA
Opioid Use Disorder in the Emergency Department: CTN 0069
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,731
- Enrollment target
NCT03023930: Completed NA study, sponsored by Yale University.
NCT03023930 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,731 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03023930, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,731 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of (1) Implementation Facilitation (IF) on rates of provision of Emergency Department (ED)-initiated buprenorphine/naloxone (BUP) treatment with referral for ongoing medication-assisted treatment (MAT) and the (2) effectiveness of IF on patient engagement in formal addiction treatment at 30 days.
Primary Outcome
The primary implementation outcome will be evaluated assessing the rate of ED-initiated BUP therapy with referral for ongoing MAT
Interventions
- OTHER Standard Dissemination Practice
- OTHER Implementation Facilitation (IF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,731 participants |
| Start Date | 2017-04-03 |
| Est. Completion | 2022-04-23 |
| Phase | NA |
What the finished NCT03023930 record still lists
NCT03023930 is an interventional study that assigns participants to a tested intervention. Its 1,731 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% higher).
The record links to 0 conditions, and to 2 interventions - of which Standard Dissemination Practice is the first listed.
NCT03023930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03023930 about?
NCT03023930 is a clinical study titled "Opioid Use Disorder in the Emergency Department: CTN 0069". The purpose of this study is to evaluate the impact of (1) Implementation Facilitation (IF) on rates of provision of Emergency Department (ED)-initiated buprenorphine/naloxone (BUP) treatment with referral for ongoing medication-assisted treatment (MAT) and the (2) effectiveness of IF on patient eng...
What is the current status of trial NCT03023930?
This trial is currently completed. It is a NA study. The enrollment target is 1,731 participants. The study started on 2017-04-03. Estimated completion is 2022-04-23.
What interventions are being tested in trial NCT03023930?
The interventions under investigation include: Standard Dissemination Practice (OTHER), Implementation Facilitation (IF) (OTHER).
Who is sponsoring clinical trial NCT03023930?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03023930's enrollment target sits among peer trials
1,731 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06413420 · 1,731 participants
SUNOSI® (Solriamfetol) Pregnancy Registry
- NCT06898034 · 1,725 participants
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
- NCT04712656 · 1,739 participants
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI